These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 4818317)

  • 1. Plasma progesterone and oestradiol-17beta changes during abortion induced by prostaglandin F2alpha.
    Tyack AJ; Lambadarios C; Parsons RJ; Stewart CR; Cooke ID
    J Obstet Gynaecol Br Commonw; 1974 Jan; 81(1):52-6. PubMed ID: 4818317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Midtrimester intra-aminotic administration of prostaglandin F2alpha in combination with an hyperosmolar urea solution: effect upon plasma levels of estradiol, progesterone, and human placental lactogen (HPL).
    Sher G; Katz M
    Acta Obstet Gynecol Scand; 1978; 57(3):223-5. PubMed ID: 665164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HCG, progesterone and 17-beta-estradiol levels during extra-amniotically induced early abortion by a new prostaglandin derivative (Sulprostone).
    Nilsson S; Zador G; Nygren KG; Wide L
    Gynecol Obstet Invest; 1981; 12(4):203-10. PubMed ID: 7250783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intrauterine instillation of prostaglandin F2ALPHA IN EARLY PREGNANCY.
    Jones JR; Gentile GP; Kemmann EK; Soriero AA
    Prostaglandins; 1975 Jun; 9(6):881-92. PubMed ID: 1162090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravaginal PGE2 in early abortion.
    Jones JR; Perez RJ
    Prostaglandins; 1974 Jul; 7(2):149-63. PubMed ID: 4852554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Termination of early gestation with vaginal prostaglandin F2 alpha tablets.
    Corlett RC; Sribyatta B; Mishell DR; Ballard C; Nakamura RM; Thorneycroft IH
    Prostaglandins; 1972 Dec; 2(6):453-64. PubMed ID: 4666665
    [No Abstract]   [Full Text] [Related]  

  • 7. Continuous extraovular administration of prostaglandin F2alpha for midtrimester abortion.
    Lauersen NH; Wilson KH
    Am J Obstet Gynecol; 1974 Sep; 120(2):273-80. PubMed ID: 4412615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Termination of early gestation with intramuscular (15S)-15 methyl prostaglandin F2 alpha.
    Brenner PF; Lumkin ME; Ballard C; Mishell DR
    Contraception; 1975 Mar; 11(3):279-87. PubMed ID: 1116367
    [No Abstract]   [Full Text] [Related]  

  • 9. Midtrimester abortion induced by single intra-amniotic instillation of two dose schedules of 15(S)-15-methyl-prostaglandin F2alpha.
    Lauersen NH; Wilson KH
    Prostaglandins; 1975 Apr; 9(4):617-25. PubMed ID: 1153812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Massive initial prostaglandin impact in postconceptional therapy.
    Csapo AI; Kivikoski A; Wiest WG
    Prostaglandins; 1972 Aug; 2(2):125-34. PubMed ID: 4653230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of luteectomy-induced progesterone-withdrawal on the oxytocin and prostaglandin response of the first trimester pregnant human uterus.
    Csapo AI; Pulkkinen MO; Kaihola HL
    Prostaglandins; 1973 Sep; 4(3):421-9. PubMed ID: 4783575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of 15(s)15-methyl-PGF2alpha-methyl ester vaginal suppositories on circulating hormone levels in early pregnancy.
    Puri CP; Laumas V; Agarwal N; Zoremthangi ; Hingorani V; Laumas KR
    Prostaglandins; 1977 Feb; 13(2):363-73. PubMed ID: 847240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of infused prostaglandin F 2 on hormonal levels during early pregnancy.
    Wentz AC; Jones GS; Graeber J
    Am J Obstet Gynecol; 1972 Dec; 114(7):908-13. PubMed ID: 4645129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The efficacy of the extraovular "prostaglandin-impact" in provoking first trimester abortion.
    Pitkanen Y; Rauramo L
    Prostaglandins; 1974 Feb; 5(3):269-74. PubMed ID: 4824817
    [No Abstract]   [Full Text] [Related]  

  • 15. The effect of prostaglandin F2alpha on the placental progesterone level in midtrimester abortion.
    Aleem FA; Schulman H; Saldana LR; Hung HC
    Am J Obstet Gynecol; 1975 Sep; 123(2):202-5. PubMed ID: 1163583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hormone levels during prostaglandin F 2 infusions for therapeutic abortion.
    Speroff L; Caldwell BV; Brock WA; Anderson GG; Hobbins JC
    J Clin Endocrinol Metab; 1972 Mar; 34(3):531-6. PubMed ID: 5011257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in estrogen levels in maternal venous plasma after intra-amniotic infusion of prostaglandin F2 for therapeutic abortion.
    Shutt DA; Smith ID; Shearman RP
    Prostaglandins; 1973 Aug; 4(2):291-9. PubMed ID: 4729615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in hormonal patterns during the first postabortion menstrual cycle after two techniques of termination of pregnancy.
    Blazar AS; Harlin J; Zaidi AA; Diczfalusy E
    Fertil Steril; 1980 May; 33(5):493-500. PubMed ID: 6768597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of uterine activity and abortion by inhibition of prostaglandin synthesis.
    Csapo AI; Henzl MR; Kaihola HL; Kivikoski A; Pulkkinen MO
    Prostaglandins; 1974 Jul; 7(1):39-47. PubMed ID: 4605187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The abortifacient action of the extraovular "prostaglandin impact" during the first half of human pregnancy.
    Enkola K
    Prostaglandins; 1974 Jan; 5(1):115-21. PubMed ID: 4816714
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.